These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34087207)

  • 1. Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein.
    Remington JM; McKay KT; Ferrell JB; Schneebeli ST; Li J
    Biophys J; 2021 Jul; 120(14):2848-2858. PubMed ID: 34087207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion.
    Jaiswal D; Kumar U; Gaur V; Salunke DM
    Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
    Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
    mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
    Fan X; Cao D; Kong L; Zhang X
    Nat Commun; 2020 Jul; 11(1):3618. PubMed ID: 32681106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles.
    Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C
    J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane.
    Schaefer SL; Jung H; Hummer G
    J Phys Chem B; 2021 Jul; 125(28):7732-7741. PubMed ID: 34255499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses
    Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S
    Front Immunol; 2021; 12():613045. PubMed ID: 33841395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion.
    Dodero-Rojas E; Onuchic JN; Whitford PC
    Elife; 2021 Aug; 10():. PubMed ID: 34463614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Shekhar N; Sarma P; Prajapat M; Avti P; Kaur H; Raja A; Singh H; Bhattacharya A; Sharma S; Kumar S; Prakash A; Medhi B
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32963099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein.
    Stincarelli MA; Quagliata M; Di Santo A; Pacini L; Fernandez FR; Arvia R; Rinaldi S; Papini AM; Rovero P; Giannecchini S
    Virus Res; 2023 Sep; 334():199170. PubMed ID: 37422270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human TMPRSS2 non-catalytic ectodomain and SARS-CoV-2 S2' subunit interaction mediated SARS-CoV-2 endocytosis: a model proposal with virtual screening for potential drug molecules to inhibit this interaction.
    Konduru GV; Nagarajaram HA
    J Biomol Struct Dyn; 2023; 41(13):6422-6433. PubMed ID: 35912718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypsin enhances SARS-CoV-2 infection by facilitating viral entry.
    Kim Y; Jang G; Lee D; Kim N; Seon JW; Kim YH; Lee C
    Arch Virol; 2022 Feb; 167(2):441-458. PubMed ID: 35079901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion.
    Borkotoky S; Dey D; Banerjee M
    J Chem Inf Model; 2021 Jan; 61(1):423-431. PubMed ID: 33412850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.
    Bollavaram K; Leeman TH; Lee MW; Kulkarni A; Upshaw SG; Yang J; Song H; Platt MO
    Protein Sci; 2021 Jun; 30(6):1131-1143. PubMed ID: 33786919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
    Raghuvamsi PV; Tulsian NK; Samsudin F; Qian X; Purushotorman K; Yue G; Kozma MM; Hwa WY; Lescar J; Bond PJ; MacAry PA; Anand GS
    Elife; 2021 Feb; 10():. PubMed ID: 33554856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.